Company Information
Member Since 6 Years
Nature of Business Exporter Year of Establishment 2014Ask for more detail from the seller
Contact Supplier
Nivolumab indicated for the treatment of patients with:
BRAF V600 wild-type unresectable or metastatic melanoma, as a single agent.
BRAF V600 mutation-positive unresectable or metastatic melanoma, as a single agent.
Unresectable or metastatic melanoma, in combination with ipilimumab.
Metastatic non-small cell lung cancer and progression on or after platinum-based chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving OPDIVO.
Advanced renal cell carcinoma who have received prior anti-angiogenic therapy.
Classical Hodgkin lymphoma (adult patients) that has relapsed or progressed after:
Connect with us
For Buyer 
For Seller 
Help 
Andheri West, Mumbai, Maharashtra 
Send Enquiry